- Home
- AYTU vs JVA Comparison
AYTU vs JVA Comparison
Compare AYTU & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- JVA
- Stock Information
- Founded
- AYTU N/A
- JVA 1971
- Country
- AYTU United States
- JVA United States
- Employees
- AYTU N/A
- JVA N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- JVA Packaged Foods
- Sector
- AYTU Health Care
- JVA Consumer Staples
- Exchange
- AYTU Nasdaq
- JVA Nasdaq
- Market Cap
- AYTU 9.8M
- JVA N/A
- IPO Year
- AYTU N/A
- JVA 2005
- Fundamental
- Price
- AYTU $1.53
- JVA $3.70
- Analyst Decision
- AYTU
- JVA
- Analyst Count
- AYTU 0
- JVA 0
- Target Price
- AYTU N/A
- JVA N/A
- AVG Volume (30 Days)
- AYTU 35.1K
- JVA 155.0K
- Earning Date
- AYTU 02-12-2025
- JVA 02-07-2025
- Dividend Yield
- AYTU N/A
- JVA N/A
- EPS Growth
- AYTU N/A
- JVA N/A
- EPS
- AYTU N/A
- JVA 0.20
- Revenue
- AYTU $79,759,000.00
- JVA $76,111,698.00
- Revenue This Year
- AYTU N/A
- JVA N/A
- Revenue Next Year
- AYTU N/A
- JVA N/A
- P/E Ratio
- AYTU N/A
- JVA $19.50
- Revenue Growth
- AYTU N/A
- JVA 17.27
- 52 Week Low
- AYTU $1.30
- JVA $0.85
- 52 Week High
- AYTU $3.45
- JVA $4.66
- Technical
- Relative Strength Index (RSI)
- AYTU 44.95
- JVA 47.93
- Support Level
- AYTU $1.48
- JVA $3.40
- Resistance Level
- AYTU $1.60
- JVA $4.01
- Average True Range (ATR)
- AYTU 0.11
- JVA 0.32
- MACD
- AYTU 0.02
- JVA -0.06
- Stochastic Oscillator
- AYTU 44.44
- JVA 23.81
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.